HomeFNCH • NASDAQ
add
Finch Therapeutics Group Inc
Previous close
$2.30
Day range
$2.16 - $2.38
Year range
$1.86 - $16.74
Market cap
3.60M USD
Avg Volume
70.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 4.68M | -48.22% |
Net income | -3.04M | 88.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.64M | 75.82% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.12M | -64.63% |
Total assets | 55.37M | -66.02% |
Total liabilities | 32.49M | -51.68% |
Total equity | 22.89M | — |
Shares outstanding | 1.61M | — |
Price to book | 0.16 | — |
Return on assets | -20.38% | — |
Return on capital | -21.36% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.04M | 88.74% |
Cash from operations | -3.71M | 74.03% |
Cash from investing | 51.00K | 200.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -3.66M | 74.39% |
Free cash flow | -2.88M | 63.04% |
About
Founded
2014
Headquarters
Website
Employees
1